We are sitting on possibly the biggest news ever in the history of CNS disease and our MC is under 1 billion dollars.
Really mystifying that no run up at all. Great results should be worth $10 billion given Biogens brain bleed was able to move the market $20 billion. That $125+ per share. Speculators should be piling in given TLD a month away. Instead, nothing.
Even if there is only 33% chance of success, that should get us to the $40+ a share all the analysts say we are worth. Instead, nothing.